Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barnes P. J., Chung K. F. PAF antagonists in asthma. Lancet. 1989 May 13;1(8646):1071–1072. doi: 10.1016/s0140-6736(89)92461-6. [DOI] [PubMed] [Google Scholar]
- Beardshaw J., MacLean L., Chan-Yeung M. Comparison of the bronchodilator and cardiac effects of hydroxyphenylorciprenaline and orciprenaline. Chest. 1974 May;65(5):507–511. doi: 10.1378/chest.65.5.507. [DOI] [PubMed] [Google Scholar]
- Crane J., Burgess C., Beasley R. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax. 1989 Feb;44(2):136–140. doi: 10.1136/thx.44.2.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Multicentre randomised clinical trial of chorion villus sampling and amniocentesis. First report. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group. Lancet. 1989 Jan 7;1(8628):1–6. [PubMed] [Google Scholar]
- Pearce N., Grainger J., Atkinson M., Crane J., Burgess C., Culling C., Windom H., Beasley R. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax. 1990 Mar;45(3):170–175. doi: 10.1136/thx.45.3.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sackett D. L., Shannon H. S., Browman G. W. Fenoterol and fatal asthma. Lancet. 1990 Jan 6;335(8680):45–46. doi: 10.1016/0140-6736(90)90168-5. [DOI] [PubMed] [Google Scholar]